StevenI.ShermanMD
Endocrinology • Houston, TXDiabetes, Lipid Metabolism, Thyroid
Professor of Medicine
Dr. Sherman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-745-7296
Education & Training
Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1991- Johns Hopkins UniversityResidency, Internal Medicine, 1986 - 1988
- Johns Hopkins UniversityInternship, Internal Medicine, 1985 - 1986
- Johns Hopkins University School of MedicineClass of 1985
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 1985 - Present
GA State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
AZ State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy Start of enrollment: 2004 Dec 01
- Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer Start of enrollment: 2001 Mar 01
- Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- 9360 citations2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Gui...Bryan R. Haugen, Erik K. Alexander, Keith C. Bible, Gerard M. Doherty, Susan J. Mandel
Thyroid. 2009-11-01 - 4781 citationsRevised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerDavid S. Cooper, Gerard M. Doherty, Bryan R. Haugen, Richard T. Kloos, Stephanie L. Lee
Thyroid. 2009-11-04 - 956 citationsSorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trialMarcia S. Brose, Christopher M. Nutting, Barbara Jarzab, Rossella Elisei, Salvatore Siena
Lancet. 2014-07-26
Journal Articles
- Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive IodineThinh Vu, Naifa L Busaidy, Maria E Cabanillas, Steven G Waguespack, Steven I Sherman, Mark Zafereo, The Journal of Clinical Endocrinology and Metabolism
Lectures
- New Medical Options for the Treatment of Advanced Thyroid CancerENDO 2019 - New Orleans, LA - 3/24/2019
Other
- Chemotherapy and immunotherapy for medullary thyroid cancerSherman SI
http://www.uptodate.com/contents/chemotherapy-and-immunotherapy-for-medullary-thyroid-cancer
UpToDate, Wolters Kluwer Health - 2013-02-21 - Chemotherapy for differentiated thyroid cancerSherman SI
http://www.uptodate.com/contents/chemotherapy-for-differentiated-thyroid-cancer
UpToDate, Wolters Kluwer Health - 2013-02-25
Press Mentions
Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024
Cabozantinib Improved Survival in Medullary Thyroid Cancer with RET MutationsOctober 23rd, 2015
Professional Memberships
- Member
- Member
- Member
- Member
- International Thyroid Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
